Literature DB >> 19880212

The human lung surfactant proteins A (SP-A) and D (SP-D) interact with apoptotic target cells by different binding mechanisms.

Anne Jäkel1, Howard Clark, Kenneth B M Reid, Robert B Sim.   

Abstract

The role of the lung surfactant proteins SP-A and SP-D in immune defence is well established. They bind to foreign organisms that invade the lungs and target them for phagocytic clearance by resident alveolar macrophages. SP-A and SP-D also bind to various apoptotic cells and facilitate their phagocytic uptake. To date, the molecular mechanisms by which the lung surfactant proteins interact with apoptotic cells and phagocytes are poorly understood. The aims of this study were to investigate further the interactions between SP-A and SP-D and apoptotic cells using human neutrophils and Jurkat cells as model systems. Specifically the binding behaviour of SP-A and SP-D with viable, early apoptotic and late apoptotic cells was investigated and compared. SP-A and SP-D show very distinct binding to the various cell types. SP-A bound to viable and early apoptotic cells in a predominantly Ca(2+)-dependent manner but the interaction with late apoptotic cells was Ca(2+)-independent, suggesting involvement of other than the lectin- or Ca(2+)-binding sites. This was consistent for neutrophils and Jurkat cells. SP-D in contrast, did not interact with viable and early apoptotic Jurkat cells but strongly and in a Ca(2+)-independent manner with late apoptotic Jurkat cells. SP-D-binding to viable and early apoptotic neutrophils was inhibited by maltose and ethylene-diamin-tetra-acetate (EDTA), suggesting lectin-binding site involvement whereas the binding to late apoptotic neutrophils was predominantly Ca(2+)-independent. These results represent a detailed study of the binding behaviour of SP-A and SP-D with different cell types and stages of viability. The mechanisms of these interactions appear to involve preferential recognition of different ligands on the apoptotic cell surface, which may include nucleic acid, phospholipid, protein and glycan structures. Copyright 2009 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19880212     DOI: 10.1016/j.imbio.2009.09.005

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  13 in total

1.  Surfactant protein D-mediated decrease of allergen-induced inflammation is dependent upon CTLA4.

Authors:  Ko-Wei Lin; Kai Yu Jen; Carlos Jose Suarez; Erika C Crouch; David L Perkins; Patricia W Finn
Journal:  J Immunol       Date:  2010-04-30       Impact factor: 5.422

2.  Surface-bound myeloperoxidase is a ligand for recognition of late apoptotic neutrophils by human lung surfactant proteins A and D.

Authors:  Anne Jäkel; Howard Clark; Kenneth B M Reid; Robert B Sim
Journal:  Protein Cell       Date:  2010-07-07       Impact factor: 14.870

3.  Surfactant protein A (SP-A) binds to phosphatidylserine and competes with annexin V binding on late apoptotic cells.

Authors:  Anne Jäkel; Kenneth B M Reid; Howard Clark
Journal:  Protein Cell       Date:  2010-02-06       Impact factor: 14.870

Review 4.  The use of CD47-modified biomaterials to mitigate the immune response.

Authors:  Jillian E Tengood; Robert J Levy; Stanley J Stachelek
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-10

Review 5.  Non-Pulmonary Immune Functions of Surfactant Proteins A and D.

Authors:  Sylvia Ujma; William G C Horsnell; Arieh A Katz; Howard W Clark; Georgia Schäfer
Journal:  J Innate Immun       Date:  2016-10-29       Impact factor: 7.349

6.  Novel role of surfactant protein A in bacterial sinusitis.

Authors:  George T Noutsios; Amanda L Willis; Julie G Ledford; Eugene H Chang
Journal:  Int Forum Allergy Rhinol       Date:  2017-07-20       Impact factor: 3.858

7.  An Insight into the Diverse Roles of Surfactant Proteins, SP-A and SP-D in Innate and Adaptive Immunity.

Authors:  Annapurna Nayak; Eswari Dodagatta-Marri; Anthony George Tsolaki; Uday Kishore
Journal:  Front Immunol       Date:  2012-06-07       Impact factor: 7.561

8.  Poractant alfa (Curosurf®) increases phagocytosis of apoptotic neutrophils by alveolar macrophages in vivo.

Authors:  Coen Hmp Willems; Florian Urlichs; Silvia Seidenspinner; Steffen Kunzmann; Christian P Speer; Boris W Kramer
Journal:  Respir Res       Date:  2012-03-09

9.  Identification of four novel DC-SIGN ligands on Mycobacterium bovis BCG.

Authors:  Maria V Carroll; Robert B Sim; Fabiana Bigi; Anne Jäkel; Robin Antrobus; Daniel A Mitchell
Journal:  Protein Cell       Date:  2010-10-07       Impact factor: 14.870

Review 10.  The Role of Collectins and Galectins in Lung Innate Immune Defense.

Authors:  Cristina Casals; María A Campanero-Rhodes; Belén García-Fojeda; Dolores Solís
Journal:  Front Immunol       Date:  2018-09-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.